Literature DB >> 11326313

Jun N-terminal kinase 1 mediates transcriptional induction of matrix metalloproteinase 9 expression.

D L Crowe1, K J Tsang, B Shemirani.   

Abstract

Tumor cell invasion and metastasis require precise coordination of adherence to extracellular matrix (ECM) and controlled degradation of its components. Invasive cells secrete proteolytic enzymes known as matrix metalloproteinases (MMPs) which degrade specific basement membrane molecules. Expression of these enzymes is regulated by multiple signaling mechanisms, including the mitogen-activated protein kinase (MAPK) pathway. One of the terminal effectors of this signaling cascade is jun N-terminal kinase 1 (JNK1) which phosphorylates the transcription factor c-jun, a component of the AP-1 complex. MMP-9 expression is regulated by two well-characterized AP-1 sites in the promoter of this gene. To determine how JNK1 activity regulated MMP-9 expression in human squamous cell carcinoma lines, we overexpressed this kinase in SCC25 cells. JNK1 overexpression induced MMP-9 protein levels and activity in this cell line. Elevated MMP-9 expression correlated with increased invasion of reconstituted basement membranes by JNK1-overexpressing clones. Site-directed mutagenesis of the MMP-9 promoter revealed that JNK1 cooperated with its transcription factor target c-jun to increase MMP-9 expression at the transcriptional level via the proximal AP-1 site. These results suggest that elevated JNK1 expression may contribute to increased MMP-9 activity and ECM invasion by tumor cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11326313      PMCID: PMC1505027          DOI: 10.1038/sj.neo.7900135

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  16 in total

1.  Transcriptional inhibition of matrix metalloproteinase 9 (MMP-9) activity by a c-fos/estrogen receptor fusion protein is mediated by the proximal AP-1 site of the MMP-9 promoter and correlates with reduced tumor cell invasion.

Authors:  D L Crowe; T N Brown
Journal:  Neoplasia       Date:  1999-10       Impact factor: 5.715

Review 2.  The mitogen-activated protein kinase signal transduction pathway.

Authors:  R J Davis
Journal:  J Biol Chem       Date:  1993-07-15       Impact factor: 5.157

3.  JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain.

Authors:  B Dérijard; M Hibi; I H Wu; T Barrett; B Su; T Deng; M Karin; R J Davis
Journal:  Cell       Date:  1994-03-25       Impact factor: 41.582

4.  alpha2beta1 integrin signaling via the mitogen activated protein kinase pathway modulates retinoic acid-dependent tumor cell invasion and transcriptional downregulation of matrix metalloproteinase 9 activity.

Authors:  H P Vo; M K Lee; D L Crowe
Journal:  Int J Oncol       Date:  1998-12       Impact factor: 5.650

5.  v-Src activates the expression of 92-kDa type IV collagenase gene through the AP-1 site and the GT box homologous to retinoblastoma control elements. A mechanism regulating gene expression independent of that by inflammatory cytokines.

Authors:  H Sato; M Kita; M Seiki
Journal:  J Biol Chem       Date:  1993-11-05       Impact factor: 5.157

Review 6.  Molecular insights into cancer invasion: strategies for prevention and intervention.

Authors:  E C Kohn; L A Liotta
Journal:  Cancer Res       Date:  1995-05-01       Impact factor: 12.701

7.  Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells.

Authors:  H Sato; M Seiki
Journal:  Oncogene       Date:  1993-02       Impact factor: 9.867

8.  Stimulation of 92-kDa gelatinase B promoter activity by ras is mitogen-activated protein kinase kinase 1-independent and requires multiple transcription factor binding sites including closely spaced PEA3/ets and AP-1 sequences.

Authors:  R Gum; E Lengyel; J Juarez; J H Chen; H Sato; M Seiki; D Boyd
Journal:  J Biol Chem       Date:  1996-05-03       Impact factor: 5.157

9.  Modulation of matrilysin levels in colon carcinoma cell lines affects tumorigenicity in vivo.

Authors:  J P Witty; S McDonnell; K J Newell; P Cannon; M Navre; R J Tressler; L M Matrisian
Journal:  Cancer Res       Date:  1994-09-01       Impact factor: 12.701

10.  Activity of type IV collagenases in benign and malignant breast disease.

Authors:  B Davies; D W Miles; L C Happerfield; M S Naylor; L G Bobrow; R D Rubens; F R Balkwill
Journal:  Br J Cancer       Date:  1993-05       Impact factor: 7.640

View more
  19 in total

1.  Exenatide exerts a potent antiinflammatory effect.

Authors:  Ajay Chaudhuri; Husam Ghanim; Mehul Vora; Chang Ling Sia; Kelly Korzeniewski; Sandeep Dhindsa; Antoine Makdissi; Paresh Dandona
Journal:  J Clin Endocrinol Metab       Date:  2011-10-19       Impact factor: 5.958

2.  Sitagliptin exerts an antinflammatory action.

Authors:  Antoine Makdissi; Husam Ghanim; Mehul Vora; Kelly Green; Sanaa Abuaysheh; Ajay Chaudhuri; Sandeep Dhindsa; Paresh Dandona
Journal:  J Clin Endocrinol Metab       Date:  2012-06-28       Impact factor: 5.958

3.  Estrogen-related abnormalities in glomerulosclerosis-prone mice: reduced mesangial cell estrogen receptor expression and prosclerotic response to estrogens.

Authors:  Mylène Potier; Michael Karl; Feng Zheng; Sharon J Elliot; Gary E Striker; Liliane J Striker
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

4.  Inflammation and extracellular matrix degradation mediated by activated transcription factors nuclear factor-kappaB and activator protein-1 in inflammatory acne lesions in vivo.

Authors:  Sewon Kang; Soyun Cho; Jin Ho Chung; Craig Hammerberg; Gary J Fisher; John J Voorhees
Journal:  Am J Pathol       Date:  2005-06       Impact factor: 4.307

5.  NAIF1 inhibits gastric cancer cells migration and invasion via the MAPK pathways.

Authors:  Mei Yang; Yu-Yu Gu; Hua Peng; Mei Zhao; Jia Wang; Sheng-Kai Huang; Xing-Hua Yuan; Jia Li; Jian-Li Sang; Qing Luo; Changzhi Huang
Journal:  J Cancer Res Clin Oncol       Date:  2014-11-29       Impact factor: 4.553

6.  Regulation of expression of matrix metalloproteinase-9 by JNK in Raw 264.7 cells: presence of inhibitory factor(s) suppressing MMP-9 induction in serum and conditioned media.

Authors:  Yun Song Lee; Huong Thi Lan Tran; Quang Van Ta
Journal:  Exp Mol Med       Date:  2009-04-30       Impact factor: 8.718

7.  Cytokines and signaling pathways regulating matrix metalloproteinase-9 (MMP-9) expression in corneal epithelial cells.

Authors:  Gabriel M Gordon; Dolena R Ledee; William J Feuer; M Elizabeth Fini
Journal:  J Cell Physiol       Date:  2009-11       Impact factor: 6.384

8.  Mitochondrial dysfunction and reactive oxygen species imbalance promote breast cancer cell motility through a CXCL14-mediated mechanism.

Authors:  Helene Pelicano; Weiqin Lu; Yan Zhou; Wan Zhang; Zhao Chen; Yumin Hu; Peng Huang
Journal:  Cancer Res       Date:  2009-03-10       Impact factor: 12.701

9.  Extracellular signals regulate rapid coactivator recruitment at AP-1 sites by altered phosphorylation of both CREB binding protein and c-jun.

Authors:  Linh N Tsai; Tony K S Ku; Nader K Salib; David L Crowe
Journal:  Mol Cell Biol       Date:  2008-04-28       Impact factor: 4.272

10.  Critical role of c-Jun overexpression in liver metastasis of human breast cancer xenograft model.

Authors:  Yan Zhang; Xiaoyun Pu; Ming Shi; Liyong Chen; Yuhua Song; Lu Qian; Guogang Yuan; Hao Zhang; Ming Yu; Meiru Hu; Beifen Shen; Ning Guo
Journal:  BMC Cancer       Date:  2007-08-01       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.